E T Tsilou

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, Division of Biometry and Epidemiology, National Eye Institute, National Institutes of Health, 10 Center Drive, Bldg 10, Rm 10N226, Bethesda, MD 20892, U S A
    Cornea 21:173-6. 2002
  2. ncbi request reprint Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 113:1002-9. 2006
  3. ncbi request reprint Eyelid myxoma in Carney complex without PRKAR1A allelic loss
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, 10 Center Drive, MSC 1860, Bldg 10 Room 10N226, Bethesda, MD 20892, USA
    Am J Med Genet A 130:395-7. 2004
  4. ncbi request reprint Milder ocular findings in Hermansky-Pudlak syndrome type 3 compared with Hermansky-Pudlak syndrome type 1
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 111:1599-603. 2004
  5. ncbi request reprint Bilateral late posterior chamber intraocular lens dislocation with the capsular bag in a patient with gyrate atrophy
    Ekaterini Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, 10 Center Drive, MSC 1860, Building 10, Room 10N226, Bethesda, MD 20892, USA
    J Cataract Refract Surg 30:1593-4. 2004
  6. pmc A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis
    E T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Br J Ophthalmol 87:28-31. 2003
  7. ncbi request reprint Retinal visualization in an eye with corneal crystals using indocyanine green videoangiography
    Ekaterini Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Institutes of Health, Bethesda, MD 20892, USA
    Am J Ophthalmol 134:123-5. 2002
  8. pmc Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 117:615-22. 2010
  9. ncbi request reprint Eye movement abnormalities in hermansky-pudlak syndrome
    Libe Gradstein
    Laboratory of Sensorimotor Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    J AAPOS 9:369-78. 2005
  10. ncbi request reprint Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types?
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Acta Ophthalmol Scand 80:196-201. 2002

Detail Information

Publications13

  1. ncbi request reprint Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, Division of Biometry and Epidemiology, National Eye Institute, National Institutes of Health, 10 Center Drive, Bldg 10, Rm 10N226, Bethesda, MD 20892, U S A
    Cornea 21:173-6. 2002
    ..With our experience with 172 patients followed up at the National Institutes of Health between 1976 and 2000, the prevalence of anterior segment complications in nephropathic cystinosis was determined...
  2. ncbi request reprint Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 113:1002-9. 2006
    ....
  3. ncbi request reprint Eyelid myxoma in Carney complex without PRKAR1A allelic loss
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, 10 Center Drive, MSC 1860, Bldg 10 Room 10N226, Bethesda, MD 20892, USA
    Am J Med Genet A 130:395-7. 2004
    ..578delTG. Immunohistochemical studies confirmed the diagnosis of myxoma. Loss of heterozygosity was not present, suggesting that haploinsufficiency alone was responsible for tumorigenesis of this eyelid lesion...
  4. ncbi request reprint Milder ocular findings in Hermansky-Pudlak syndrome type 3 compared with Hermansky-Pudlak syndrome type 1
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 111:1599-603. 2004
    ..To compare clinically 2 different subtypes of Hermansky-Pudlak syndrome (HPS), type 1 (HPS-1) and type 3 (HPS-3)...
  5. ncbi request reprint Bilateral late posterior chamber intraocular lens dislocation with the capsular bag in a patient with gyrate atrophy
    Ekaterini Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, 10 Center Drive, MSC 1860, Building 10, Room 10N226, Bethesda, MD 20892, USA
    J Cataract Refract Surg 30:1593-4. 2004
    ..One IOL was initially repositioned by nonsurgical manipulations, while the other required surgical repositioning. Eventually, IOL exchange was performed successfully in both eyes...
  6. pmc A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis
    E T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Br J Ophthalmol 87:28-31. 2003
    ..Aim: To evaluate the safety and efficacy of a new topical cysteamine formulation, stable at room temperature, for the treatment of corneal cystine crystals in cystinosis...
  7. ncbi request reprint Retinal visualization in an eye with corneal crystals using indocyanine green videoangiography
    Ekaterini Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Institutes of Health, Bethesda, MD 20892, USA
    Am J Ophthalmol 134:123-5. 2002
    ..To report a patient in whom clear imaging of the retina, impossible with conventional methods, was obtained using indocyanine green (ICG) videoangiography...
  8. pmc Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 117:615-22. 2010
    ..All 4 syndromes have been associated with various physical abnormalities. As part of a genotype/phenotype/cancer susceptibility study, we determined the prevalence of ophthalmic manifestations in these 4 syndromes...
  9. ncbi request reprint Eye movement abnormalities in hermansky-pudlak syndrome
    Libe Gradstein
    Laboratory of Sensorimotor Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    J AAPOS 9:369-78. 2005
    ..Although it is known that patients with HPS exhibit nystagmus, the nature of these abnormal eye movements has not been studied...
  10. ncbi request reprint Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types?
    Ekaterini T Tsilou
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Acta Ophthalmol Scand 80:196-201. 2002
    ..Usher syndrome types I and II are clinical syndromes with substantial genetic and clinical heterogeneity. We undertook the current study in order to identify ocular symptoms and signs that could differentiate between the two types...
  11. doi request reprint Neurofibromatosis type 2
    Ashok R Asthagiri
    Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1414, USA
    Lancet 373:1974-86. 2009
    ..We review the molecular pathogenesis, genetics, clinical findings, and management strategies for neurofibromatosis type 2...
  12. pmc Ocular pathologic features of Hermansky-Pudlak syndrome type 1 in an adult
    Min Zhou
    National Eye Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    Arch Ophthalmol 124:1048-51. 2006
  13. ncbi request reprint Rieger's anomaly and other ocular abnormalities in association with osteogenesis imperfecta and a COL1A1 mutation
    Benjamin U Nwosu
    Pediatric Endocrinology Inter Institute Training Program, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892, USA
    Ophthalmic Genet 26:135-8. 2005
    ..We speculate that the course of his disease and, perhaps, its co-existence with OI could be exacerbated by his collagen type-I defect, although no causality can be established by this report of a single case...